Диссертация (1140242), страница 22
Текст из файла (страница 22)
DeVilliers E. Relationship between steroid hormone contraceptives and HPV,cervical intraepithelial neoplasia and cervical carcinoma./ Е. DeVilliers//Virology.-2003.-№l.-Р.162-169.80. Donne A.J. The role of HPV type in Recurrent Respiratory Papillomatosis/ A.J.Donne, L. Hampsonb, J.J. Homer, I.N.Hampsonb.// Laryngoscope – 2007. №106. –Р.223-229.81.Doyle D.J. Recurrent respiratory papillomatosis: juvenile versus adult forms. /D.J. Doyle, G.J.
Gianoli, Т. Espinola, R.H. Miller //Laryngoscope – 1997.- №104.– Р.523-527.82. Eckel H.E. Surgery of Larynx and Trachea/ H.E. Eckel, М. Remacle – Berlin:Springer, 2010. – 308 p.83. Eileen M. Burd Human Papillomavirus and Cervical Cancer/ М. Eileen // Clin.Microbiol.Rev.-2003.-Vol.16.-№1.-P.1-17.84. El-Bitar M.A. Powered instrumentation in the treatment of recurrent respiratorypapillomatosis: an alternative to the carbon dioxide laser./М.А. El-Bitar, G.H.
Z alzal// Arch Otolaryngol Head Neck Surg.- 2002.-№ 128(4).-Р.425-428.85. Elo J. Combined therapy with Isoprinosine and CO2 laser microsurgery for thetreatment of laryngeal papillomatosis./ J.Elo// Arch. Otorhino-laryngol. – 1988. –Vol.244.- №6. – P.342-345.86. Endres D.R. Acyclovir in the treatment of recurrent respiratory papillomatosis.A pilot study/ D.R. Endres, N.M. Bauman, D.
Burke // Ann Otol Rhinol Laryngol.– 1994. - №103. – P.301-305.87. Förster G. Juvenile laryngeal papillomatosis--immunisation with the polyvalentvaccine gardasil./ G.Förster, С. Boltze,J.Seidel, M. Pawlita, A.Müller //Laryngorhinootologie.//2008.-№87(11).-Р.796-799.88. Gale N. Laryngeal papillomatosis: molecular, histopathological, and clinicalevaluation/ N.Gale, М.Poljak, V. Kambic // Virchows Arch.
– 1994. – Vol. 425.№7. – P. 291-295.14489.Gerein V. Incidence, age at onset, and potential reasons of malignanttransformation in recurrentrespiratory papillomatosis patients: 20 years experience/V. Gerein , Е. Rastorguev , J. Gerein, W. Draf , J. Schirren// Otolaryngol Head NeckSurg.-2005.-№ 132(3).-Р.392-394.90. Gélinas J.F. Lung involvement in juvenile onset recurrent respiratorypapillomatosis: a systematic review of the literature/ J.F. Gélinas , J. Manoukian, А.Côté// Int J Pediatr Otorhinolaryngol.
-2008.-№72(4).-Р.433-52.91. Gerein V. Use of interferon-alpha in recurrent respiratory papillomatosis: 20year follow-up./ V,Gerein, Е. Rastorguev, J. Gerein,// Ann Otol Rhinol Laryngol.2005.-№l.-Р.463-471.92. Gierek T. Lymphocytes, neutrophils and serum immunoglobulins in patientswith precancerous states of the larynx/ Т. Gierek, J.L. Lisiewich, G. Astaldi, J.Pilch// Laryngoscope. -–1979. – Vol.
89.- №7. – P.1145-1150.93. Gómez M.A. Detection of human papillomavirus in juvenile laryngealpapillomatosis using polymerase chain reaction. / М.А. Gómez, R. Drut, M.M, R.M.Drut- 1995. -№55(3).-Р.213-217р.94.Gonzalez V.I.МComplications in transoral C02 laser surgery for carcinoma ofthe larynx and hypopharynx./ V.I. Gonzalez, В.М.
Sprekelsen, J.L. Alejandro //Head Neck.- 2003.- №25(5).-Р. 382-388р.95. Green G. Pathogenesis and treatment of juvenile onset recurrent respiratorypapillomatosis/ G. Green, N. Bauman, R. Smith // Otolaryngologic Clinics of NorthAmerica -2000.-Vol.33-№1.-Р.45-4696. Gross G.E. Human papilloma virus infection / G.E. Gross, R. Barrasso //A.ClinicalAtlas,Berlin.-Wisbaden:UelsteinMosby.-1997.-P.433.97.
Guo Y.L. Long-term therapeutic effects of tracheotomy on children withrecurrent laryngeal papillomatosis/ Y.L Guo , T.S. Zhang // Laryngoscope. -–2012.– Vol. 45.- №3. – P.1123-1124.14598. Hallmo P. Laryngeal papillomatosis with human papillomavirus DNAcontracted by a laser surgeon./ Р. Hallmo, О. Naess // Eur Arch Otorhinolaryngol. 1999.-№248(7).-Р.425-427.99. Hartnick C.J. Efficacy of treating children with anterior commissure and truevocal fold respiratory papilloma with the 585-nm pulsed-dye laser. /C.J.
Hartnick,M.E. Boseley, R.A. Franco, Jr Pransky // Arch Otolaryngol Head Neck Surg. -2007.№133(2).-Р 127-130.100. Hermann J.S. Laryngeal sequelae of recurrent respiratory papillomatosissurgery in children./ J.S. Hermann, P. Pontes, L.L. Weckx, R. Fujita, М. Avelino,S.S. Pignatari // Rev Assoc Med Bras.- 2012.-№58(2).-Р.204-208.101. Hester R.P. Reliability of a staging assessment system for recurrent respiratorypapillomatosis. / R.P. Hester, C.S.
Derkay, B.L. Burke, L Lawson // Int J PediatrOtorhinolaryngol.- 2003.-№67(5).-Р.505-509р.102. Hillman R.J. Changes in HPV infection in patients with anogenital warts andtheir partners/ R.J. Hillman, B.K. Ryait, M. Botcherby, D. Taylor-Robinson //Genitourin. Med. – 1993. – Vol.69. - №6. – P.450-456.103. Holinger P.H. Benign tumors of the larynx/ P.H. Holinger, K.C. Johnston //Ann.
Otol. Rhinol. Laryngol. – 1951. – Vol.60, №2. – P. 496 - 500.104. Jakubikova J. Is it possible to predict the clinical development of juvenilepapillomatosis of the larynx / J. Jakubikova, B: Ondras // 7th International Congressof Pediatric Otorhinolaryngology.
- Helsinki, 1998. - P. 209105. Kasapoglu F. Endolaryngeal cordectomy using cold instruments for treatmentof T1 glottic cancers./ F. Kasapoglu, L. Erisen, H. Coskun, O. Basut. // Eur ArchOtorhinolaryngol.-2007.-№64(9).-Р.1065-1070.106. Kashima H.K. A comparison of risk factors in juvenile-onset and adult-onsetrecurrent respiratory papillomatosis/ H.K. Kashima, F. Shah, A. Lyles, R. Glackin,146N. Muhammad, L. Turner, S. Van Zandt, S. Whitt, K. Shah // Laryngoscope.
-2002.-№102(1).-Р.9-13.107. Kashima H.K. Recurrent respiratory papillomatosis / H.K. Kashima,P.Mounts, K. Shah // Obstet Gynecol Clin North Am.- 1996.-№ 23(3).-Р.699-706.108. Kashima H. Sites of predilection in recurrent respiratory papillomatosis./ H.Kashima, P. Mounts, B. Leventhal, R.H. Hruban // Ann Otol Rhinol Laryngol. 1993.-№102.-Р.580-583.109. Kashima H.K. Polymerase chain reaction identification of humanpapillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis/H.K. Kashima,T. Kessis,P.
Mounts,K. Shah// Otolaryngol Head NeckSurg.- 1991.- №104.-Р.191-195.110. Karatayli-Ozgursoy S. Risk Factors for Dysplasia in Recurrent RespiratoryPapillomatosis in an Adult and Pediatric Population. / S.Karatayli-Ozgursoy, J.A.Bishop, А.Hillel, L. Akst , S.R. Best // Ann Otol Rhinol Laryngol.- 2015.-№4-Р.5457.111. Kaye J. N. Viral load as a determinant for transmission of human papillomatosistype 16 from mother to child / J.
N. Kaye, J. Cason, F.B. Pakarian // J. Med. Virol.– 1994. – Vol.44 - №4. – P.415-421.112. Kimberlin D.W. Pharmacotherapy of recurrent respiratory papillomatosis/D.W. Kimberlin // Expert Opin Pharmacother. – 2002. – Vol.3.-№8. – P.1091-1099.113.Klacansky I. Lieba juvenilnej papillomatozy hrtana interferonom alevamisolom/ I. Klacansky, I. Jakubikova, I. Borecky // Ces. Otolaryngol. – 1986.– Vol.35- №5. – P.273-277.114. Koutsky L. Epidemiology of genital human papillomavirus infection./ L.Koutsky // Am J Med.- 2007.- №102.-Р.3-8.115. Koutsky L.A. Genital papillomavirus in-fections: current knowledge and futureprospects/ L.A. Koutsky, P Wolner-Hanssen. // Obstet Gynecol Clin North.-1989.№16.-Р.541–564.147116. Kramer S.S.
Pulmonary manifestations of juvenile laryngotrachealpapillomatosis/ S.S. Kramer, W.D. Wehunt, J.T. Stocker, H. Kashima // AJR Am JRoentgenol.- 1985.-№144(4).-Р.687-694.117. Larson D.A. Epidemiology of recurrent respiratory papillomatosis/ D.A.Larson, C.S. Derkay // APMIS. -2010.-№118.-Р. 450-454.118. Lee R.G. Photodynamic therapy of cottontail rabbit papillomavirus-inducedpapillomas in a severe combined immunodeficient mouse xenograft system/ R.G.Lee, M.A. Vecchiotti, J.
Heaphy, A. Panneerselvam, M.D. Schluchter, N.L.Oleinick,P. Lavertu,K.N. Alagramam,J.E. Arnold,R.C. Sprecher //Laryngoscope.- 2010.-№120(3).-Р. 618-624.119. Li D. Application of coblation treatment via endoscopy in epiglottic benigntumors/ D. Li, Q. Zhang, М. Ding// Clin Otolaryngol.- 2015.-№29(7).-Р.616-617.120.
Limsukon A. Regression of recurrent respiratory papillomatosis with elecoxiband erlotinib combination therapy/ A. Limsukon, I. Susanto, G.W. Hoo, S.M.Dubinett, R.K. Batra // Chest.- 2009.-№136(3).-Р.924-926.121. Lindeberg H. Laryngeal papillomas: clinical aspects in a series of 231 patients/H. Lindeberg// Clin Otolaryngol. -1989. - № 14.
- P. 333-342:122. Lindeberg H. Laryngeal papillomas: the epidemiology in a Danishsubpopulation 1965–1984./ H. Lindeberg, O. Elbrond// Clin Otolaryngol Allied.1990.-№15.-Р.125–131.123. Long Y.T. Recurrent respiratory papillomatosis/ Y.T. Long, A. Sani // Asian J.Surg.-2003.-Vol.2.- №26.-P.112-116.124. Lundquist P.G. Ultrastructural features of human juvenile laryngealpapillomatosis. / P.G.
Lundquist, L. Frithiol, J. Wersall //Acta Otolaryng. – 1975. –Vol.80.- №1. – P.137-149.125.Lusar B. Human papillomaviruses infection and expression of p53 and c-erbB2 protein in laryngeal papillomas/ B. Lusar, N. Gale, V. Kambic,Otolaryngol. Suppl. (Stockh). – 1997. – Vol.527. – P.120-124.// Acta.148126.
Lucs A.V. Constitutive overexpression of the oncogene Rac1 in the airway ofrecurrent respiratorypapillomatosis patients is a targetable host-susceptibility factor/A.V. Lucs, R. Wu, V. Mullooly, A.L. Abramson, B.M Steinberg //. Mol Med. 2012.-№ 30.-Р.244-249.127. Ma L.
Clinical study of tracheotomies children with juvenile onset recurrentrespiratory papillomatosis/ L. Ma, J. Wang, D. Han, J. Ye, W. Xu // Lin ChuangEr Bi Yan Hou Ke Za Zhi.- 2006.-№20(15).-Р.704-706.128. Mahnke C.G. Recurrent laryngeal papillomatosis. Retrospective analysis of95 patients and review of the literature/ C.G. Mahnke, O. Fröhlich, B.M. Lippert,J.A. Werner // Otolaryngol Pol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
